Sangamo BioSciences Announces Presentation At The 35th Annual J.P. Morgan Healthcare Conference
Theo nguồn tin Sangamo BioSciences trên trang mạng của prnewswire.com RICHMOND, Calif., Jan. 4, 2017 /PRNewswire/ — Sangamo BioSciences, Inc. (NASDAQ: SGMO), the leader in therapeutic genome editing, announced today…